Berberine inhibited radioresistant effects and enhanced anti-tumor effects in the irradiated-human prostate cancer cells

被引：19

作者：

Hur J.-M. ^{[1
]}

Kim D. ^{[2
]}

机构：

[1] Chong Kun Dang Healthcare Crop. Research Center

[2] Radiation Research Center for Bio-Technology, Korea Atomic Energy Research Institute

来源：

Toxicological Research | 2010年 / 26卷 / 2期

关键词：

Apoptosis; Berberine; Radiation; Radioresistant;

D O I：

10.5487/TR.2010.26.2.109

中图分类号：

学科分类号：

摘要：

The purpose of this study was to elucidate the mechanism underlying enhanced radiosensitivity to 60Co Y- irradiation in human prostate PC-3 cells pretreated with berberine. The cytotoxic effect of the combination of berberine and irradiation was superior to that of berberine or irradiation alone. Cell death and Apoptosis increased significantly with the combination of berberine and irradiation. Additionally, ROS generation was elevated by berberine with or without irradiation. The antioxidant NAC inhibited berberine and radiation-induced cell death. Bax, caspase-3, p53, p38, and JNK activation increased, but activation of Bcl-2, ERK, and HO-1 decreased with berberine treatment with or without irradiation. Berberine inhibited the anti-apoptotic signal pathway involving the activation of the HO-1/NF-?B-mediated survival pathway, which prevents radiation-induced cell death. Our data demonstrate that berberine inhibited the radioresistant effects and enhanced the radiosensitivity effects in human prostate cancer cells via the MAPK/ caspase-3 and ROS pathways.

引用

页码：109 / 115

页数：6

共 28 条

[1]

Baldwin A.S., The NF-kappa B and I kappa B proteins: new discoveries and insights, Annu. Rev. Immunol., 14, pp. 649-683, (1996)

[2]

Bergman P.J., Harris D., Radioresistance, chemoresistance, and apoptosis resistance, The past, resent, and future, Vet. Clin. N. Am-Small., 27, pp. 47-57, (1997)

[3]

Blumenstein M., Hossfeld D.K., Duhrsen U., Indirect radiation leukemogenesis in DBA/2 mice: increased expression of B2 repeats in FDC-P1 cells transformed by intracisternal Aparticle transposition, Ann. Hematol., 76, pp. 53-60, (1998)

[4]

Bohnke A., Westphal F., Schmidt A., El-Awady R.A., Dahm-Daphi J., Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumor cells, Int. J. Radiat. Biol., 80, pp. 53-63, (2004)

[5]

[6]

Bristow R., Benchimol S., Hill R., The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy, Radiother. Oncol., 40, pp. 197-223, (1996)

[7]

Bristow R., Benchimol S., Hill R., The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy, Radiother. Oncol., 40, pp. 197-223, (1996)

[8]

Carson C.C., Carcinoma of the prostate: overview of the most common malignancy in men, N. C. Med. J., 67, pp. 122-126, (2006)

[9]

Colombo R., Naspro R., Salonia A., Montorsi F., Raber M., Suardi N., Sacca A., Rigatti P., Radical prostatectomy after previous prostate surgery: clinical and functional outcomes, J. Urol., 176, pp. 2459-2463, (2006)

[10]

Corbiere C., Liagre B., Terro F., Beneytout J.L., Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells, Cell Res., 14, pp. 188-196, (2004)

← 1 2 3 →